Canada markets open in 4 hours 13 minutes

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
87.23-0.87 (-0.99%)
At close: 4:00PM EST
Sign in to post a message.
  • A
    1 year to the release preliminary data from EARLY TAVR. Expanding the iceberg of aortic stenosis to the largest tier, the asymptomatic patient.
  • C
    I've dedicated about 5% of my portfolio to EW for several years and wish I'd have increased that, no doubt, but the high P/E held me back. Help me out folks; Can this company protect its patent or proprietary advantage moving forward? It seems counterintuitive to pay triple my original price but this thing seems to only gain momentum and market share. Thanks.
  • g
    Zero heart procedures being scheduled. ICU beds are full of covid patients.
  • s
    Target Raised by Morgan Stanley Overweight USD 88 » USD 99
  • M
    Lots of insider selling the last few weeks.
  • J
    This stock is far I have 1,400% return and will continue to go up gradually.
  • n
    Is this the move some of us have been waiting for or are the markets still to choppy?
    Quick story: I bought in around $68 with more ammo available but never used any, just a couple weeks ago. It has floated around these prices for a bit and I was waiting for it to make a move. I missed the daily move upwards but this seems like big news for a company that is very well managed. I want to add more shares but I would also like to know the sentiment of the long positions. Is the China and settlement news as big as I hope?
  • S
    I work in the heart surgery business now for 26 years, involved with 4000 procedures , and I can tell you I bought $400,000 worth of this stock. Of course, hope I'm not wrong right? It takes a long time to get a valve to market, and the Edwards Sapien TAVR valve has superb market share and results. We did 15, then 50 and then 150 last year. Patients are learning about it , and that's what Mick Jagger got. I have great confidence in this stock, and also Medtronic, another holding. I bought in EW at 190, and again at 230. I don't think in 5 years I'll be doing Aortic Valve Replacements, just repairs or combination procedures if the heart is already going to be exposed. Also, the newer coatings on all valves are so much improved from the 80's and 90's one can expect a valve to last your lifetime. EW is also a really good company with lots of other product lines. I feel the same way as I did about Intuitive Surgical.
  • J
    Proxy statement wants increase in shares to effect a 3:1 stock split. Is this a good idea? I know it should not make any difference, but not many companies are splitting their shares today. Any opinions appreciated.
  • A
    I suspect the recent run up in the stock is due to the upcoming release of PARTNER III data for aortic valve replacement in low risk patients. This will increase the patient pool for aortic valve replacement by several fold and render conventional read - surgical AVR all but obsolete. which would you pick 4 week recovery or 4 day recovery. This is underappreciated by the retail investor but well known by the institutional investors. Good luck
  • g
    Latest heart valve just approved by China today. Huge market opened up.
  • S
    No major increase in the stock price in the last 6 months. Any possible reasons?
  • J
    Stock usually drops after earning and starts to rise within a week - will be in the 170-180 range by the end of the year.
    One of the great medical innovative companies
  • Y
    Yahoo Finance Insights
    Edwards Lifesciences reached an all time high at 91.80
  • B
    I follow heart related stocks and Edwards is a leader
  • J
    Pleased to see the settling of the longstanding Abbott v. Edwards transcatheter mitral valve lawsuit. As you can imagine if you are already using the Edwards Sapien aortic valve system it is an easy transition to add the PASCAL mitral repair device to your toolkit for most cathlabs and ORs.
  • N
    EW is always expensive. When I first looked at it in 2013, the share then was at $64 while earning barely hit $2/share. Fast forward to today in 2020, after the 1:3 split last week, the share is back to about the same level ($68-$70) while earning per share comes in around $2/share or less. This time I decided to jump in with both feet today and probably too soon. Will hold on to my shares and check back in 2023 to see if I get a positive return.
  • d
    Jeffries notes two potential sources of errors in their “third” review of data , both of which would not capture the “true” number of new unit sales.- which interestingly is the basis of their report. As such, their report is premature and not factual. A buying opportunity has been created.
  • G
    Planning to buy calls on EW and ILMN. Will they beat earnings and guide higher is a big question in this tricky market. Also will market get excited and provide a bump in stock prices?
  • W
    Amazing how "informed" commenters are not after a stock split. So much about market share efficiency....